They just didn't raise enough money and will be in a worse position than when they went into suspension, with nearly double the register.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025